Human CD8+ CD57- TEMRA cells: Too young to be called "old"

Area of Science:

• Immunology
• Cell Biology
• Transplantation Immunology

Background:

• Antigen-specific T-cell differentiation impacts immune responses post-allogeneic stem cell transplantation (SCT).
• CD8+ T-cells include effector memory (TEM) and TEMRA subsets, with TEMRA comprising most terminally differentiated cells.
• The role of the senescence marker CD57 in TEMRA cells was previously undefined.

Purpose of the Study:

• To investigate the functional relevance of CD57 in human CD8+ TEMRA cells.
• To determine if CD57 can differentiate TEMRA cells into distinct functional subsets.

Main Methods:

• Isolation and characterization of CD57+ and CD57- CD8+ TEMRA cells from healthy donors and SCT patients.
• Analysis of telomere length, proliferation (BrdU uptake), cytokine release (IFN-γ), cytotoxicity, and in vitro phenotypic changes.
• Assessment of CMV-specific T-cells post-allogeneic SCT.

Main Results:

• CD57- TEMRA cells possess longer telomeres and higher proliferative and IFN-γ release capacity compared to CD57+ TEMRA cells.
• CMV-specific CD57- TEMRA cells show increased peptide sensitivity in functional assays.
• Cytotoxicity was comparable between CD57+ and CD57- TEMRA subsets.
• CD57- TEMRA cells demonstrated plasticity, differentiating into TEM cells and acquiring CD57 expression, unlike CD57+ cells which showed limited change and cell death.

Conclusions:

• CD57 serves as a marker to delineate CD8+ TEMRA cells into a terminally differentiated CD57+ population and a functionally distinct, "younger" CD57- subset.
• The CD57- TEMRA subset exhibits significant proliferative capacity and differentiation plasticity, offering potential for immune reconstitution strategies.
• These findings redefine the understanding of TEMRA cell heterogeneity and function in immune responses.